The United Laboratories International Holdings Limited
The United Laboratories International Holdings Limited Fundamental Analysis
The United Laboratories International Holdings Limited (3933.HK) shows moderate financial fundamentals with a PE ratio of 13.31, profit margin of 15.88%, and ROE of 12.64%. The company generates $8.6B in annual revenue with weak year-over-year growth of 0.14%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 51.2/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 3933.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak3933.HK struggles to generate sufficient returns from assets.
Valuation Score
Excellent3933.HK trades at attractive valuation levels.
Growth Score
Weak3933.HK faces weak or negative growth trends.
Financial Health Score
Excellent3933.HK maintains a strong and stable balance sheet.
Profitability Score
Moderate3933.HK maintains healthy but balanced margins.
Key Financial Metrics
Is 3933.HK Expensive or Cheap?
P/E Ratio
3933.HK trades at 13.31 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 3933.HK's PEG of -0.44 indicates potential undervaluation.
Price to Book
The market values The United Laboratories International Holdings Limited at 1.59 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 8.59 times EBITDA. This is generally considered low.
How Well Does 3933.HK Make Money?
Net Profit Margin
For every $100 in sales, The United Laboratories International Holdings Limited keeps $15.88 as profit after all expenses.
Operating Margin
Core operations generate 17.31 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $12.64 in profit for every $100 of shareholder equity.
ROA
The United Laboratories International Holdings Limited generates $6.74 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
The United Laboratories International Holdings Limited produces operating cash flow of $891.40M, showing steady but balanced cash generation.
Free Cash Flow
The United Laboratories International Holdings Limited produces free cash flow of $275.05M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.14 in free cash annually.
FCF Yield
3933.HK converts 2.29% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
13.31
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.44
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.59
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.39
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.29
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.83
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.13
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.11
vs 25 benchmark
How 3933.HK Stacks Against Its Sector Peers
| Metric | 3933.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 13.31 | 28.45 | Better (Cheaper) |
| ROE | 12.64% | 763.00% | Weak |
| Net Margin | 15.88% | -45265.00% (disorted) | Strong |
| Debt/Equity | 0.29 | 0.34 | Neutral |
| Current Ratio | 1.83 | 2795.60 | Neutral |
| ROA | 6.74% | -16588.00% (disorted) | Weak |
3933.HK outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews The United Laboratories International Holdings Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
47.96%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
274.04%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
60.31%
Industry Style: Defensive, Growth, Innovation
High Growth